Amlodipine Besylate/Atorvastatin Calcium Hydrate

苯磺酸氨氯地平/阿托伐他汀钙

Report date: 2022/03/08 16:45:35

Base Information

Drug NameAmlodipine Besylate/Atorvastatin Calcium Hydrate
Drug Alias Nameアムロジピンベシル酸塩・アトルバスタチンカルシウム水和物Atorvastatin/amlodipine阿托伐他汀钙/苯磺酸氨氯地平氨氯地平/阿托伐他汀钙Atorvastatin Calcium Hydrate/Amlodipine Besylate +[10] 
ClassificationSmall molecules
Mechanisms of ActionHMG-CoA reductase inhibitorsVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channelHMG-CoA reductase
Therapy Area/IndicationsHypercholesterolemiaHyperlipidemiasHyperlipoproteinemia Type II +[8] 
Global Approved IndicationsHypercholesterolemiaHyperlipidemiasHyperlipoproteinemia Type II +[8] 
Approved Indications in ChinaHypercholesterolemiaHyperlipidemiasHypertension +[5] 
Original Approved Country/TerritoryUnited States
Original Approved Date2004/01/30
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsYes Amlodipine BesylateAtorvastatin Calcium Hydrate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncPharmacia
Inactive CompaniesN/A
Active IndicationsHypercholesterolemiaHyperlipidemiasHyperlipoproteinemia Type II +[7] 
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeC10BX03
Related LinksWikipediaKEGG